Clene Nanomedicine Announces Top-Line Results from Phase 2 RESCUE-ALS Clinical Trial

NEXT STORY
U.S. FDA Authorizes InteliSwab™ COVID-19 Rapid Tests for OTC Single-Use, At-Home Testing for Symptomatic People and Accepts Data for Delta Variant Detection
PREV STORY
iOnctura to Share Preclinical Data on IOA-289 at SITC in November
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2020

author_avatar
NASDAQ Market News

Novartis Cosentyx® shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study

author_avatar
NASDAQ Market News

Alkahest Announces Peer-Reviewed Publication Demonstrating Safety and Tolerability of GRF6019 in Patients with Mild-to-Moderate Alzheimer’s Disease

author_avatar
NASDAQ Market News